Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: Fierce 15 nominations are now open! We're looking for the best and brightest in biotech.
Lykos Therapeutics
Biotech
AbbVie pens $2B-plus neuro pact with Gilgamesh
AbbVie has inked a $2 billion biobucks deal with Gilgamesh aimed at developing next-gen therapies for psychiatric disorders.
Gabrielle Masson
May 13, 2024 5:57pm
FDA advisers to weigh first psychedelic therapy in early June
May 7, 2024 11:10am
Psychedelic biotech MAPS PBC rebrands to Lykos, snags $100M
Jan 5, 2024 10:50am